Jinghua Pharmaceutical Group subsidiary Lu Huaxian led the development of an industry standard which was approved by the National Standards Committee.

Jinghua Pharmaceutical Group (002349.SZ) announced that the industry standard for "1,3-dioxolane" led by its subsidiary Shandong Luhua Senxuan New Materials Co., Ltd. (referred to as "Luhua Senxuan") has been approved by the National Standards Committee and officially announced by the Ministry of Industry and Information Technology. The standard will be officially implemented starting from March 1, 2026.